Multiple Myeloma Coverage from Every Angle

Kenneth C. Anderson, MD, and Francesca M. Gay, MD, on Newly Diagnosed Multiple Myeloma: Results From the FORTE Trial

Posted: Tuesday, August 15, 2017

Kenneth C. Anderson, MD, of Dana-Farber Cancer Institute, and Francesca M. Gay, MD, of the University of Torino, discuss interim study findings on carfilzomib-lenalidomide-dexamethasone vs carfilzomib-cyclophosphamide-dexamethasone induction in newly diagnosed disease.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.